Douglas Gazarian
Affiliations: | 2016- | Psychology | Clark University, Worcester, MA, United States |
Google:
"Douglas Gazarian"Parents
Sign in to add mentor| Mark Zimmerman | research assistant | Warren Alpert Medical School of Brown University | |
| Kristin A. Lane | research assistant | 2012-2013 | Bard College |
| William D. Ellison | research assistant | 2014-2015 | Trinity University |
| Michael E. Addis | grad student | Clark University (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gazarian D, Addis ME, Jampel JD, et al. (2022) Contexts of Concealment: Initial Validation of Three Disclosure Avoidance Process Measures. Journal of Personality Assessment. 1-17 |
| Jampel JD, Gazarian D, Addis ME, et al. (2019) Traditional Masculinity Ideology and Diagnostic Aversion Predict Symptom Expression in a Community Sample of Distressed Men Sex Roles. 82: 704-715 |
| Zimmerman M, Gazarian D, Multach M, et al. (2017) A clinically useful self-report measure of psychiatric patients' satisfaction with the initial evaluation. Psychiatry Research. 252: 38-44 |
| Zimmerman M, Multach MD, Clark HL, et al. (2016) Inclusion/exclusion criteria in late life depression antidepressant efficacy trials. International Journal of Geriatric Psychiatry |
| Zimmerman M, Holst CG, Clark HL, et al. (2016) The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years. Cns Drugs |
| Gazarian D, Multach MD, Ellison WD, et al. (2016) Does 'fear of dying' indicate a more severe presentation of panic disorder? Journal of Anxiety Disorders. 40: 52-57 |
| Zimmerman M, Clark HL, Multach MD, et al. (2016) Variability in the substance use disorder exclusion criterion in antidepressant efficacy trials. Journal of Affective Disorders. 198: 39-42 |
| Zimmerman M, Clark HL, Multach MD, et al. (2016) Symptom Severity and the Generalizability of Antidepressant Efficacy Trials: Changes During the Past 20 Years. Journal of Clinical Psychopharmacology |
| Zimmerman M, Multach M, Walsh E, et al. (2016) Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity. Cns Drugs |
| Zimmerman M, Clark HL, Multach MD, et al. (2015) Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling. Journal of Affective Disorders. 190: 357-361 |